Protein‐DNA Competition at the Bio‐Nano Interface: Structural and Biological Insights From Graphene Oxide Coronas
Source abstract
Abstract
Abstract Understanding interactions between nanomaterials and biomolecules is essential for advancing biomedical nanotechnologies. This study investigates how double‐stranded DNA of varying sizes affects the protein corona (PC) surrounding Graphene Oxide (GO) nanosheets in DNA‐supplemented human plasma. The findings reveal that DNA plays a pivotal role in modulating the PC composition through dynamic competition governed by factors like surface charge, affinity, and DNA fragment size. At lower DNA concentrations, competition between DNA and proteins for binding sites on GO leads to a corona predominantly composed of proteins, with some DNA molecules also bound. However, as the DNA concentration increases beyond a threshold, a shift occurs. DNA increasingly outcompetes proteins for binding sites, resulting in a two‐component corona enriched with both DNA and proteins. Notably, the proportion of DNA within the corona progressively increases with rising DNA concentration, while the protein content decreases. This dynamic interplay between DNA and proteins has significant biological implications. A monotonic increase in Toll‐like receptor 9 (TLR9) activation is observed as the DNA content within the corona increases. As the corona composition and its influence on cellular responses are crucial, this study emphasizes the relevance of exploring competition at the bio‐nano interface for the advancement of these applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Molecular Medicine Sapienza University of Rome Viale Regina Elena 291 Rome 00161 Italy
Department of Molecular Medicine Laboratory Affiliated to Istituto Pasteur Italia Fondazione Cenci Bolognetti Sapienza University of Rome Rome 00161 Italy
Department of Chemistry Sapienza University of Rome P.le Aldo Moro 5 Rome 00185 Italy
Funding
Ministero dell'Università e della Ricerca
References (71)
Show source-provided references
1. 10.1021/nn202458g10.1021/nn202458g ↗
2. 10.1002/anie.20070046510.1002/anie.200700465 ↗
3. 10.1021/nn901372t10.1021/nn901372t ↗
4. 10.1073/pnas.060858210410.1073/pnas.0608582104 ↗
5. 10.1039/C1CS15233E10.1039/C1CS15233E ↗
6. 10.1016/S0169-409X(97)00128-210.1016/S0169-409X(97)00128-2 ↗
7. 10.1016/S0163-7827(03)00033-X10.1016/S0163-7827(03)00033-X ↗
8. M. P.Monopoli C.Aberg A.Salvati K. A.Dawson Nano‐Enabled Medical ApplicationsNew York Jenny Stanford Publishing2020 205.10.1201/9780429399039-7 ↗
9. 10.1039/C9LC00341J10.1039/C9LC00341J ↗
10. 10.1039/C6RA25493D10.1039/C6RA25493D ↗
11. 10.1016/j.nantod.2022.10165710.1016/j.nantod.2022.101657 ↗
12. 10.1021/acsami.4c0001410.1021/acsami.4c00014 ↗
13. 10.3390/nano1224443410.3390/nano12244434 ↗
14. 10.1002/med.2176710.1002/med.21767 ↗
15. 10.1039/D0NR02379E10.1039/D0NR02379E ↗
16. 10.1038/s41578-024-00658-110.1038/s41578-024-00658-1 ↗
17. 10.1038/s41565-021-00924-110.1038/s41565-021-00924-1 ↗
18. 10.1038/s41598-020-57943-610.1038/s41598-020-57943-6 ↗
19. 10.1116/6.000043910.1116/6.0000439 ↗
20. 10.1039/C9EN00938H10.1039/C9EN00938H ↗
21. 10.1021/acsmeasuresciau.2c0000310.1021/acsmeasuresciau.2c00003 ↗
22. 10.1080/17435390.2019.157751010.1080/17435390.2019.1577510 ↗
23. 10.1016/j.talanta.2019.12048710.1016/j.talanta.2019.120487 ↗
24. 10.1002/smsc.20230006410.1002/smsc.202300064 ↗
25. 10.1021/acsabm.2c0081210.1021/acsabm.2c00812 ↗
26. 10.5858/arpa.2018-0901-SA10.5858/arpa.2018-0901-SA ↗
27. 10.1016/j.xgen.2022.10024210.1016/j.xgen.2022.100242 ↗
28. 10.1063/1.510093210.1063/1.5100932 ↗
29. 10.1016/j.molliq.2019.03.01010.1016/j.molliq.2019.03.010 ↗
30. 10.3389/fbioe.2020.0049110.3389/fbioe.2020.00491 ↗
31. 10.1039/C9NR01413F10.1039/C9NR01413F ↗
32. 10.1039/C8NH00318A10.1039/C8NH00318A ↗
33. 10.3390/polym1405103210.3390/polym14051032 ↗
34. 10.1186/s12951-023-02030-x10.1186/s12951-023-02030-x ↗
35. 10.3389/fcell.2021.73219210.3389/fcell.2021.732192 ↗
36. 10.1038/s41416-022-01876-610.1038/s41416-022-01876-6 ↗
37. 10.3389/fimmu.2023.124434510.3389/fimmu.2023.1244345 ↗
38. 10.1016/j.bjid.2015.10.01110.1016/j.bjid.2015.10.011 ↗
39. 10.1002/jmv.2677610.1002/jmv.26776 ↗
40. 10.1063/1.480784810.1063/1.4807848 ↗
41. 10.1196/annals.1448.02210.1196/annals.1448.022 ↗
42. 10.2353/jmoldx.2009.08009810.2353/jmoldx.2009.080098 ↗
43. 10.1196/annals.1318.00410.1196/annals.1318.004 ↗
44. 10.1196/annals.1448.01610.1196/annals.1448.016 ↗
45. 10.3390/cancers1419465810.3390/cancers14194658 ↗
46. 10.1021/acs.jpcc.6b0846910.1021/acs.jpcc.6b08469 ↗
47. 10.1039/C8EN01408F10.1039/C8EN01408F ↗
48. 10.1016/j.fsigen.2011.07.01410.1016/j.fsigen.2011.07.014 ↗
49. 10.1039/D4NR01850H10.1039/D4NR01850H ↗
50. 10.1021/pr500951510.1021/pr5009515 ↗
51. 10.3390/ijms15071233510.3390/ijms150712335 ↗
52. 10.1093/nar/gkh62410.1093/nar/gkh624 ↗
53. 10.1039/D0NH00333F10.1039/D0NH00333F ↗
54. 10.1155/2009/58795610.1155/2009/587956 ↗
55. 10.1039/C5CS00217F10.1039/C5CS00217F ↗
56. 10.1002/pmic.20030044910.1002/pmic.200300449 ↗
57. 10.1016/j.jcis.2023.10.09510.1016/j.jcis.2023.10.095 ↗
58. 10.1038/bjc.2014.47010.1038/bjc.2014.470 ↗
59. 10.2217/nnm-2019-040110.2217/nnm-2019-0401 ↗
60. 10.1126/scitranslmed.abj100810.1126/scitranslmed.abj1008 ↗
61. Mahey A. · 2022
62. 10.1073/pnas.231963412110.1073/pnas.2319634121 ↗
63. 10.1016/j.addr.2022.11435610.1016/j.addr.2022.114356 ↗
64. 10.3390/cancers1511298310.3390/cancers15112983 ↗
65. 10.1016/j.tips.2024.05.00310.1016/j.tips.2024.05.003 ↗
66. 10.3390/cancers1301009310.3390/cancers13010093 ↗
67. 10.1039/C8NR09245A10.1039/C8NR09245A ↗
68. 10.1016/j.sintl.2020.10002510.1016/j.sintl.2020.100025 ↗
69. 10.1016/j.biocel.2015.09.00210.1016/j.biocel.2015.09.002 ↗
70. 10.1039/D1BM00488C10.1039/D1BM00488C ↗
71. 10.1039/D1NA00211B10.1039/D1NA00211B ↗